[Late treatment related complications of Hodgkin's disease]
- PMID: 9781154
[Late treatment related complications of Hodgkin's disease]
Abstract
Patients cured of Hodgkin's disease are at high risk for developing late treatment-related complications. Radiation therapy is responsible for non malignant complications such as pulmonary, digestive, thyroid and cardiac toxicity. Chemotherapy is mainly responsible for pulmonary toxicity and gonadal dysfunction in females and in males, whatever the age at treatment. Hodgkin's disease therapy may also result in secondary malignancy which is considered the most serious complication. White the use of non leukaemogenic chemotherapy can limit the incidence of secondary leukaemia, that of secondary solid tumours is still increasing, being 15% after 20 years. Altogether, malignant and non malignant complications are still responsible for a non negligible overmortality.
Similar articles
-
Late complications of therapy of Hodgkin's disease: prevention and management.Curr Hematol Rep. 2004 Jan;3(1):27-33. Curr Hematol Rep. 2004. PMID: 14695846 Review.
-
Late complications of Hodgkin's disease management.J Natl Cancer Inst Monogr. 1990;(10):55-60. J Natl Cancer Inst Monogr. 1990. PMID: 2189477 Review.
-
The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.Cancer J Sci Am. 1999 Nov-Dec;5(6):325-33. Cancer J Sci Am. 1999. PMID: 10606471 Review.
-
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.Br J Cancer. 1999 Oct;81(3):476-83. doi: 10.1038/sj.bjc.6690718. Br J Cancer. 1999. PMID: 10507773 Free PMC article.
-
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.Haematologica. 2008 Mar;93(3):398-404. doi: 10.3324/haematol.12120. Epub 2008 Feb 11. Haematologica. 2008. PMID: 18268277
Publication types
MeSH terms
LinkOut - more resources
Medical